Interact to see
Advertisement
Advertisement
HGHRX vs JNGLX
HGHRX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
HGHRX vs. JNGLX commentary
Jun 04, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a Buy and JNGLX is a Buy.
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.66B vs. HGHRX (801M). JNGLX pays higher dividends than HGHRX: JNGLX (0.36) vs HGHRX (0.00). HGHRX was incepted earlier than JNGLX: HGHRX (18 years) vs JNGLX (26 years). HGHRX (1.63) is less costly to investors than JNGLX (0.80). HGHRX is a more actively managed with annual turnover of: 40.00 vs. JNGLX (35.00). HGHRX has a lower initial minimum investment than JNGLX: HGHRX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -12.72 vs. HGHRX (-15.86). JNGLX return over 5 years is better than : 5.93 vs. HGHRX (-18.62).
| HGHRX | JNGLX | HGHRX / JNGLX | |
| Total Expense Ratio | 1.63 | 0.80 | 204% |
| Annual Report Gross Expense Ratio | 1.63 | 0.80 | 204% |
| Fund Existence | 18 years | 26 years | - |
| Gain YTD | -6.913 | -5.038 | 137% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 801M | 4.66B | 17% |
| Annual Yield % from dividends | 0.00 | 0.36 | - |
| Returns for 1 year | -15.86 | -12.72 | 125% |
| Returns for 3 years | -5.12 | 7.80 | -66% |
| Returns for 5 years | -18.62 | 5.93 | -314% |
| Returns for 10 years | -20.93 | 8.51 | -246% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement